Personalized Therapy With Dalcetrapib Improves Outcomes for Cardiovascular Disease

A new personalized therapy with dalcetrapib for cardiovascular disease has been demonstrated by researchers at the Montreal Heart Institute.

The research team analyzed 5749 patients who received dalcetrapib or placebo and provided DNA in a clinical study. They found a strong association between the effects of dalcetrapib and a specific gene called ADCY9 (adenylate cyclase 9) on chromosome 16, particularly for a specific genetic variant (rs1967309).

PLAC Test for Cardiovascular Disease
Ensure your heart health by getting a PLAC test. Prevent heart attack and stroke by detecting your risk of developing cardiovascular disease.

In patients with the genetic profile AA at rs1967309, there was a 39 percent reduction in combined clinical outcomes including heart attacks, strokes, unstable angina, coronary revascularizations and cardiovascular deaths with dalcetrapib compared to placebo. From a second study it was seen that patients with the favorable genetic profile also benefited from reduction in the amount of atherosclerosis (thickened walls) of their carotid artery walls with dalcetrapib.

Lead investigator Jean-Claude Tardif said, “These results will lead to a genetics-guided clinical study in patients with the appropriate genetic background to allow review by health regulatory agencies and to provide personalized therapy with dalcetrapib. It also offers great hope for precision treatments for patients with cardiovascular diseases and for curbing atherosclerosis, the first cause of mortality in the world. “

This discovery may pave the way for a new era in cardiovascular medicine, with personalized or precision drugs. The study appears in the Journal Circulation Cardiovascular Genetics.

Risk of Death Through Cardiovascular Disease can be Reduced by Running for Just a Few Minutes in a Day
A new study suggests that a person’s risk of death from cardiovascular disease can be significantly reduced if he or she runs at slow speeds for just a few minutes every day.

Source-Medindia

Fructose Does Not Impact Emerging Indicator for Cardiovascular Disease
New research has found that fructose, the sugar often blamed for the obesity epidemic, does not itself have any impact on an emerging marker for the risk of cardiovascular disease known as postprandial triglycerides.

Blood-vessel Gene Could Fight Cancer, Cardiovascular Diseases
Researchers from the University of Leeds have discovered, Piezo1, a gene which creates blood vessel and this gene could be used to fight cancer, heart disease and strokes.